Cancer Drug from GSK Cuts Death Risk by Nearly Half in Trial
London, UK – A recent clinical trial conducted by GSK has shown promising results in treating blood cancer patients. The study found that the drug developed by the pharmaceutical company can reduce the risk of death by almost half in patients with advanced stages of the disease. The drug, which goes by the name of … Read more